Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1870 1
1871 1
1945 1
1951 2
1952 2
1954 1
1964 1
1967 1
1968 4
1969 5
1970 8
1971 15
1972 13
1973 10
1974 6
1975 10
1976 9
1977 9
1978 9
1979 8
1980 13
1981 9
1982 4
1983 8
1984 11
1985 8
1986 10
1987 15
1988 33
1989 32
1990 44
1991 53
1992 45
1993 49
1994 48
1995 38
1996 63
1997 67
1998 102
1999 90
2000 83
2001 88
2002 108
2003 100
2004 127
2005 137
2006 168
2007 167
2008 183
2009 161
2010 214
2011 265
2012 297
2013 379
2014 544
2015 744
2016 851
2017 960
2018 1210
2019 1361
2020 1514
2021 675
Text availability
Article attribute
Article type
Publication date

Search Results

9,889 results
Results by year
Filters applied: . Clear all
Page 1
Medical Cannabis.
Ebbert JO, Scharf EL, Hurt RT. Ebbert JO, et al. Mayo Clin Proc. 2018 Dec;93(12):1842-1847. doi: 10.1016/j.mayocp.2018.09.005. Mayo Clin Proc. 2018. PMID: 30522595 Review.
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In …
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United S …
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the clinic. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed rese …
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the …
Medical Cannabis for Neuropathic Pain.
Lee G, Grovey B, Furnish T, Wallace M. Lee G, et al. Curr Pain Headache Rep. 2018 Feb 1;22(1):8. doi: 10.1007/s11916-018-0658-8. Curr Pain Headache Rep. 2018. PMID: 29388063 Review.
Recent scientific discovery has elucidated the intricate role of the endocannabinoid system in the pathophysiology of neuropathic pain. As societal perceptions change, and legislation on medical cannabis relaxes, there is growing interest in the use of medical
Recent scientific discovery has elucidated the intricate role of the endocannabinoid system in the pathophysiology of neuropathic pain. As s …
Practical considerations in medical cannabis administration and dosing.
MacCallum CA, Russo EB. MacCallum CA, et al. Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. Eur J Intern Med. 2018. PMID: 29307505 Review.
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certain nations, this ignorance of cannabis pharmacology and therapeutics has become untenable. ...Dose initiation should commence at modes …
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certai …
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
Hill KP, Palastro MD. Hill KP, et al. Pol Arch Intern Med. 2017 Nov 30;127(11):785-789. doi: 10.20452/pamw.4123. Epub 2017 Oct 25. Pol Arch Intern Med. 2017. PMID: 29067992 Free article. Review.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. ...As the number of patient requests for medical cannabis has be …
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as leg …
Medical Cannabis: A plurimillennial history of an evergreen.
Pisanti S, Bifulco M. Pisanti S, et al. J Cell Physiol. 2019 Jun;234(6):8342-8351. doi: 10.1002/jcp.27725. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417354 Review.
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written records found in ancient texts from the sacred Vedic foundational texts of Ayurvedic medicine (about 800 before current era [BCE]) to the firs …
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written re …
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W. Sarzi-Puttini P, et al. Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997. Expert Rev Clin Immunol. 2019. PMID: 31512536 Review.
Introduction: Clinicians involved in pain management can finally include cannabis or cannabis-related products in their therapeutic armamentarium as a growing number of countries have approved them for pain relief. ...Areas covered: A review of studies carried out d …
Introduction: Clinicians involved in pain management can finally include cannabis or cannabis-related products in their therap …
A selective review of medical cannabis in cancer pain management.
Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O'Hearn S. Blake A, et al. Ann Palliat Med. 2017 Dec;6(Suppl 2):S215-S222. doi: 10.21037/apm.2017.08.05. Epub 2017 Aug 23. Ann Palliat Med. 2017. PMID: 28866904 Free article. Review.
Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alternative therapeutic op-tions. Anecdotal evidence suggests that medical cannabis has potential to effectively manage pain in t …
Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alt …
Medical Cannabis.
Hill KP. Hill KP. JAMA. 2020 Feb 11;323(6):580. doi: 10.1001/jama.2019.17403. JAMA. 2020. PMID: 32044944 No abstract available.
Medical cannabis and mental health: A guided systematic review.
Walsh Z, Gonzalez R, Crosby K, S Thiessen M, Carroll C, Bonn-Miller MO. Walsh Z, et al. Clin Psychol Rev. 2017 Feb;51:15-29. doi: 10.1016/j.cpr.2016.10.002. Epub 2016 Oct 12. Clin Psychol Rev. 2017. PMID: 27816801 Review.
Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis
Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence r …
9,889 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page